Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mateos

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Frontiers in Oncology|October 22, 2024
POLQ immunostaining behaves as a prognostic factor for pancreatic carcinomaLaura Del Puerto-Nevado, María J Fernández-Aceñero, Arancha Cebrián, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 23, 2016
Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007R Marcos-Gragera, J Galceran, C Martos, et al.
Bioorganic Chemistry|August 2, 2024
Design, synthesis and biological evaluation of glucose metabolism inhibitors as anticancer agentsYao Cheng, John Patrick Jones, Tsz Tin Yu, et al.
Cell Death and Differentiation|January 24, 2015
CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinomaM Teodorczyk, S Kleber, D Wollny, et al.
Molecular Therapy. Oncology|September 8, 2025
Aurora kinase A drives non-canonical YAP1/TAZ crosstalk to sustain primary resistance to anti-EGFR therapies in colorectal cancerAnxo Rio-Vilariño, Ana Garcia-Bautista, Aiora Cenigaonandia-Campillo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 7, 2018
Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 yearsR Marcos-Gragera, M Solans, J Galceran, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 18, 2017
Cancer incidence in Spain, 2015J Galceran, A Ameijide, M Carulla, et al.
British Journal of Cancer|March 12, 2024
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cellsAnxo Rio-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, et al.
Nature Biotechnology|November 28, 2017
Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiencyMarella D Canny, Nathalie Moatti, Leo C K Wan, et al.
Persoonia|January 18, 2024
Fungal Planet description sheets: 1383-1435P W Crous, J Boers, D Holdom, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Frontiers in Oncology|October 22, 2024
POLQ immunostaining behaves as a prognostic factor for pancreatic carcinomaLaura Del Puerto-Nevado, María J Fernández-Aceñero, Arancha Cebrián, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 23, 2016
Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007R Marcos-Gragera, J Galceran, C Martos, et al.
Bioorganic Chemistry|August 2, 2024
Design, synthesis and biological evaluation of glucose metabolism inhibitors as anticancer agentsYao Cheng, John Patrick Jones, Tsz Tin Yu, et al.
Cell Death and Differentiation|January 24, 2015
CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinomaM Teodorczyk, S Kleber, D Wollny, et al.
Molecular Therapy. Oncology|September 8, 2025
Aurora kinase A drives non-canonical YAP1/TAZ crosstalk to sustain primary resistance to anti-EGFR therapies in colorectal cancerAnxo Rio-Vilariño, Ana Garcia-Bautista, Aiora Cenigaonandia-Campillo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 7, 2018
Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 yearsR Marcos-Gragera, M Solans, J Galceran, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 18, 2017
Cancer incidence in Spain, 2015J Galceran, A Ameijide, M Carulla, et al.
British Journal of Cancer|March 12, 2024
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cellsAnxo Rio-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, et al.
Nature Biotechnology|November 28, 2017
Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiencyMarella D Canny, Nathalie Moatti, Leo C K Wan, et al.
Persoonia|January 18, 2024
Fungal Planet description sheets: 1383-1435P W Crous, J Boers, D Holdom, et al.
Pageof 20